Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CV.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CV.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CV.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CV.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DJ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DJ.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DJ.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DJ.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DJ.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.73EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.73ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.73ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.73EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.73EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.370EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.370ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.370ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.370EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.370EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.370ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.370ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.118EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.118ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.118ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used